Prostate Cancer

Integrating radiological and clinical data for clinically significant prostate cancer detection with machine learning techniques. February 10, 2025

ATAD2 Drives Prostate Cancer Progression to Metastasis. February 10, 2025

Implementing and Optimizing Universal Germline Genetic Testing for Patients with Prostate Cancer in Clinical Practice Consider. February 10, 2025

Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth. February 10, 2025

MR-guided Transrectal Focal Laser Ablation for Localized Low- and Intermediate Risk Prostate Cancer: Initial Outcomes Using an Integrated Laser Ablation System. February 10, 2025

Long-term outcomes of LDR-brachytherapy for localized prostate cancer. February 10, 2025

Associations between socioeconomic factors and PSA testing in a population-based organised testing programme and routine healthcare: a register-based study of 50-year-old men. February 10, 2025

Trends in outpatient radical prostatectomy and same day discharge for prostate cancer: Analysis of the National Inpatient Sample and Nationwide Ambulatory Surgery Sample. February 7, 2025

Enzalutamide and Docetaxel in Combination With Androgen Deprivation for Men With Metastatic Hormone-Sensitive Prostate Cancer: ENZADA, a Phase II Trial. February 7, 2025

The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update. February 7, 2025

Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC. February 7, 2025

Targeting AXL inhibits the growth and metastasis of prostate cancer in bone. February 7, 2025

Incisional PSMA PET/CT-positive recurrences in prostate cancer- is there an implication on clinical care? February 7, 2025

Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy. February 6, 2025

Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials. February 6, 2025

Refining partial gland ablation for localised prostate cancer: the FALCON project. February 6, 2025

Ultra-fast biparametric MRI in prostate cancer assessment: Diagnostic performance and image quality compared to conventional multiparametric MRI. February 6, 2025

Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer. February 6, 2025

Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy. February 5, 2025

Repeatability, reproducibility, and the effects of radiotherapy on radiomic features of lowfield MR-LINAC images of the prostate. February 5, 2025

Page 1 of 1457